vorinostat has been researched along with Cancer of Gallbladder in 3 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, S | 1 |
Li, F | 1 |
Pan, L | 1 |
Yang, Z | 1 |
Shu, Y | 1 |
Lv, W | 1 |
Dong, P | 1 |
Gong, W | 1 |
Zhang, P | 2 |
Guo, Z | 1 |
Wu, Y | 1 |
Hu, R | 1 |
Du, J | 2 |
He, X | 1 |
Jiao, X | 2 |
Zhu, X | 1 |
Jiang, G | 1 |
Gao, J | 1 |
Li, L | 1 |
3 other studies available for vorinostat and Cancer of Gallbladder
Article | Year |
---|---|
BRD4 inhibitor and histone deacetylase inhibitor synergistically inhibit the proliferation of gallbladder cancer in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Divisio | 2019 |
Histone Deacetylase Inhibitors Inhibit the Proliferation of Gallbladder Carcinoma Cells by Suppressing AKT/mTOR Signaling.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cyclin D1; G1 Phase Cell Cyc | 2015 |
SAHA down-regulates the expression of indoleamine 2,3-dioxygenase via inhibition of the JAK/STAT1 signaling pathway in gallbladder carcinoma cells.
Topics: Antineoplastic Agents; Antiviral Agents; Blotting, Western; Gallbladder Neoplasms; Gene Expression R | 2013 |